Evidence map›Paper›PMID 23787699›Full record

ArticlePrion

RML prions act through Mahogunin and Attractin-independent pathways.

Teresa M Gunn, George A Carlson

Open access · bronzeAbstract read
In one paragraph

Article in Prion. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Teresa M GunnMcLaughlin Research Institute; Great Falls, MT USA.
George A Carlson
Great Falls Clinic · USMcLaughlin Research Institute · US

Funding

TRANSGENETICS OF CHIMERIC PROTEINS IN PRION REPLICATION &DISEASEP01NS041997 · NINDS · MC LAUGHLIN RESEARCH INSTITUTE · PI DEARMOND, STEPHEN J. · 2001 to 2011
$15.0M
NINDS NIH HHS NS041997NINDS NIH HHS P01 NS041997
6 · The paper itself

Abstract

While the conversion of the normal form of prion protein to a conformationally distinct pathogenic form is recognized to be the primary cause of prion disease, it is not clear how this leads to spongiform change, neuronal dysfunction and death. Mahogunin ring finger-1 (Mgrn1) and Attractin (Atrn) null mutant mice accumulate vacuoles throughout the brain that appear very similar to those associated with prion disease, but they do not accumulate the protease-resistant scrapie form of the prion protein or become sick. A study demonstrating an interaction between cytosolically-exposed prion protein and MGRN1 suggested that disruption of MGRN1 function may contribute to prion disease pathogenesis, but we recently showed that neither loss of MGRN1 nor MGRN1 overexpression influences the onset or progression of prion disease following intracerebral inoculation with Rocky Mountain Laboratory prions. Here, we show that loss of ATRN also has no effect on prion disease onset or progression and discuss possible mechanisms that could cause vacuolation of the central nervous system in Mgrn1 and Atrn null mutant mice and whether the same pathways might contribute to this intriguing phenotype in prion disease.

Indexed as

AnimalsMembrane ProteinsMiceMice, KnockoutPrion DiseasesPrionsUbiquitin-Protein LigasesVacuolesAtrn protein, mouseMembrane ProteinsMgrn1 protein, mousePrionsUbiquitin-Protein LigasesATRNAttractinMahogunin ring finger-1MGRN1prion diseasePrPscrapiespongiform encephalopathytransmissible spongiform encephalopathyvacuolation

Identifiers

PMID23787699
PMCPMC3904309
OpenAlexW2014491156

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.